Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL - Wenning, S; Oldenburg, J; Eichler, H; Escuriola-Ettingshausen, C; Fontana, P; Heidersdorf, B; Kramer, S; Kremer Hovinga, J; Miesbach, W; Pfrepper, C; Reimering, S; Rizzi, M; Sachs, U; Scholz, U; Udvardi, P T; von der Weid, N; Wieland, I; Albisetti, M (Hämostaseologie, 2025)